PDI Announces First ''Pulsing Team'' Agreement

PDI, Inc. (NASDAQ:PDII), a provider of commercialization services to the biopharmaceutical industry, today announced it has entered into an agreement with a well known, USA specialty pharmaceutical company to provide a dedicated pulsing team. These representatives will provide a promotional blitz selling products to a unique group of targeted doctors. "Pulsing Teams” is a new service within the PDI ON DEMAND suite of highly customized, flexible and value-driven sales solutions. This six month agreement has a contract value of approximately $2 million. Michael Marquard, PDI’s CEO, said, "We are pleased to be providing this unique and strategic service for our client. As the only provider of Pulsing Teams, we are extremely pleased with the level of interest for this service which can drive revenue for seasonal products, increase pull-through in key regions, or respond to unexpected market events. This engagement is further testament to the changing needs of the industry and the rapidly growing demand for the unique services provided by PDI.” PDI will leverage its highly qualified and pre-certified ON DEMAND talent pool and proven product training expertise to rapidly field a dedicated sales team. Additionally, PDI will provide complete sales force automation and comprehensive back-end sales operations support for the Pulsing Team, thereby ensuring rapid and seamless deployment. Field Sales management of the Pulsing Sales team will also be handled by PDI at the request of the client. About PDI PDI provides commercialization services for established and emerging biopharmaceutical companies. The Company is dedicated to maximizing the return on investment for its clients by providing strategic flexibility; sales, marketing and commercialization expertise. PDI operates in two areas, Sales Services and Marketing Services. Our Sales Services include Performance Sales Teams™, which are dedicated teams for specific customers; Select Access™, our targeted sales solution that leverages an existing infrastructure; and PDI ON DEMAND, innovative sales services that provide rapid, customized sales force solutions tailored to meet local, regional, and seasonal needs. Our Marketing Services include marketing research and consulting services through TVG in Dresher, PA., and medical communications services through Pharmakon in Schaumburg, IL. In addition, PDI is a high-quality provider of ACCME-accredited continuing medical education through Vital Issues in Medicine (VIM®), located in Dresher, PA. PDI's experience extends across multiple therapeutic categories and includes office and hospital based initiatives. PDI's commitment is to deliver innovative solutions, unparalleled execution and superior results for its customers. Recognized as an industry pioneer, PDI remains committed to continuous innovation and to retaining the industry's highest-quality employees. For more information, please visit the Company's website at www.pdi-inc.com. Forward-Looking Statements This press release contains forward-looking statements regarding future events and financial performance. These statements involve a number of risks and uncertainties and are based on numerous assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, the termination of or material reduction in the size of any of our customer contracts, the loss of our or our customers' intellectual property rights, our ability or inability to secure new business to offset the recent loss of customer contracts and the terms of any replacement business we secure, changes in our operating expenses, FDA, legal or accounting developments, competitive pressures, failure to meet performance benchmarks in significant contracts, changes in customer and market requirements and standards, the impact of any stock repurchase programs, the adequacy of the reserves PDI has taken, the financial viability of certain companies whose debt and equity securities we hold, the outcome of certain litigation, PDI's ability to implement its current and future business plans, and the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2006, and PDI's subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K. The forward-looking statements in this press release are based upon management's reasonable belief as of the date hereof. PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.